BioSpace News Archive

CEO Connection® announced a partnership agreement with Bind, the nation’s first-ever on-demand health insurance model. CEO Connection On-Demand Health Insurance powered by Bind will provide CEO Connection mid-market member companies a solution to make healthcare more affordable.

FeNO is an established biomarker for airway inflammation in human exhaled breath

This is the online equivalent of a walk-in clinic, where a patient will be able to connect to a provider on the same day, no appointment needed

Through this acquisition Sunstar gains global distribution of this product line, expanding its position as a global leader in the development and commercialisation of oral healthcare products, mainly marketed under the GUM brand.

Ortho Care™ Recognized for Its Ability to Anticipate Customer Needs in Hospitals, Labs and Blood Banks Around the World

Ashok Chander, PhD, Cellanyx’s co-founder, technology inventor and former CEO, will become Chief Technology Officer.

Non-medical switching is a strategy used to reduce administrative expenses by switching the prescription for a stable patient to a “preferred” or cheaper pharmaceutical drug.

Retro Fitness, a national low-cost, high-value fitness franchise, announced today it has added two new franchisees totaling four new franchise agreements with local entrepreneurs Joe and Shawna Liotine for Tampa, FL and Jim Sparling for Central, NJ.

Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY) inventor of Cellvizio®, the multidisciplinary probe-based and needle-based confocal laser endomicroscopy (pCLE/nCLE) platform, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the use of the Cellvizio AQ-Flex™ 19 Confocal Miniprobe

Dupixent showed significant improvement on every primary and secondary endpoint in patients with severe CRSwNP who had failed previous treatment with surgery and/or systemic corticosteroids